Sygnum Europe AG Receives MiCAR CASP Licence from FMA Liechtenstein
On 26 June 2026, the Liechtenstein Financial Market Authority (FMA) granted Sygnum Europe AG a licence as a crypto-asset service provider (CASP) under Article 63 of Regulation (EU) 2023/1114, the Markets in Crypto-Assets Regulation (MiCAR). The authorisation places the Vaduz-registered entity among the growing cohort of firms holding a regulated EU-passport-ready CASP authorisation ahead of the post-transitional MiCAR enforcement environment.
What the FMA Authorisation Covers
The FMA's published notice confirms that Sygnum Europe AG (registered number FL-0002.722.200-8) obtained its CASP status with effect from 26 June 2026. The licence was issued under the core MiCAR authorisation article that applies across the European Economic Area, meaning the firm can, in principle, passport its approved crypto-asset services into EU member states without seeking separate national approval in each jurisdiction.
Scope of Authorised Services
The FMA notice references the specific crypto-asset services for which Sygnum Europe AG obtained authorisation. The source document does not reproduce the full list of individual service categories in the publicly available excerpt, but MiCAR Article 63 authorisations typically span activities such as operating a trading platform, custody and administration on behalf of clients, exchange services, and portfolio management. Compliance teams reviewing this authorisation should consult the FMA's official licence register for the precise service scope before assuming full-service equivalence.
Why Liechtenstein as a MiCAR Jurisdiction
Liechtenstein is a member of the European Economic Area and has transposed MiCAR into national law, making FMA-issued CASP licences valid across the EEA under the single passport mechanism. For firms with existing operations or clients in the German-speaking region, the jurisdiction offers a stable legal environment, a well-established FMA supervisory framework, and proximity to Switzerland-based institutional networks.
Contrast with FMA Enforcement Activity
The FMA is not purely an approvals body. Accounting and compliance teams should note that the same authority has a visible enforcement track record. FMA Liechtenstein's prior enforcement action against CI Fund Services AG illustrates that a licence can be revoked when ongoing conduct requirements are not met. Obtaining authorisation is a threshold, not a finish line.
MiCAR Licensing Patterns Across the EEA
Sygnum Europe AG's approval is one of several CASP authorisations being processed across EEA jurisdictions as the MiCAR transitional period closes. Regulators across EU and EEA states have been clear that firms without proper authorisation face wind-down orders, as ESMA has already signalled. The pattern reflects a maturing regulatory landscape where institutional-grade crypto firms are treating regulatory capital as a strategic asset.
For context on how another EEA jurisdiction has handled the transition, see how the Malta VFA-to-CASP transition illustrates MiCA licensing in practice. The comparison is instructive: Malta approached the shift through a defined conversion pathway for existing VFA holders, while Liechtenstein, which did not have a pre-existing crypto-specific regime of the same type, processes applications under its MiCAR transposition framework directly.
Practical Implications for Accounting Firms and CFOs
When a counterparty or client entity obtains a new CASP licence, the compliance and accounting implications are immediate on several dimensions.
Counterparty Due Diligence
Firms onboarding Sygnum Europe AG as a service provider or exchange counterparty can now reference the FMA's public register as part of their regulated-entity verification process. Under MiCAR, operating without authorisation exposes both the unlicensed entity and, in certain circumstances, the firms that continue to engage with it to regulatory scrutiny.
Accounting Treatment of CASP-Intermediated Holdings
Where client crypto assets are held in custody by a licensed CASP, the accounting classification question turns partly on whether the custodian is regulated. A MiCAR-authorised custodian provides a cleaner narrative for segregation of assets from the custodian's own balance sheet, which matters under IFRS and emerging IFRS 20 standards for crypto-asset disclosures. Practitioners should document the authorisation status of any CASP used in custody arrangements.
AML and KYC File Updates
A newly issued licence changes the risk profile of an existing business relationship. AML compliance officers should trigger a file review when a counterparty's regulatory status changes, including when a previously unlicensed or provisionally operating entity obtains full CASP authorisation. The FMA licence date of 26 June 2026 should be logged as a material event in client or counterparty records.
Source: FMA Liechtenstein
FAQ
It is an authorisation issued under Article 63 of EU Regulation 2023/1114 (MiCAR) by the Liechtenstein FMA, allowing Sygnum Europe AG to provide specific crypto-asset services within the EEA. The licence carries the single-passport right, so the firm can offer its approved services across EU and EEA member states without a separate local authorisation in each country.
The FMA Liechtenstein granted the licence on 26 June 2026, according to the official FMA publication referenced in this article.
Yes. Liechtenstein is an EEA member and has transposed MiCAR into national law. An FMA-issued CASP authorisation carries EEA passporting rights, allowing the licensed firm to provide its approved services across EU and EEA member states subject to the relevant notification procedures.
They should update the counterparty's due diligence file to record the new regulatory status, note the licence date as a material event, verify the authorised service scope against the regulator's public register, and reassess the risk rating of the relationship accordingly.
The FMA has also revoked licences where ongoing conduct requirements were not met, as seen in the CI Fund Services AG case. A new authorisation demonstrates regulatory approval at a point in time, but firms must continue to meet capital, governance, AML, and conduct obligations to retain it.